MedPage Today) -- Although the FDA has expanded approvals for two respiratory syncytial virus (RSV) vaccines to include high-risk young and middle-age adults, CDC advisors have not yet moved to recommend the vaccine in these groups. In June...
Copyright © 2023 cape-breton.com. Toady's News. All Rights Reserved